Adagio Medical Holdings, Inc.
ADGM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $269 | $300 | $189 | $270 |
| % Growth | -10.3% | 58.7% | -30% | – |
| Cost of Goods Sold | $1,937 | $1,306 | $875 | $1,158 |
| Gross Profit | -$1,668 | -$1,006 | -$686 | -$888 |
| % Margin | -620.1% | -335.3% | -363% | -328.9% |
| R&D Expenses | $4,634 | $15,399 | $17,855 | $15,355 |
| G&A Expenses | $0 | $4,752 | $0 | $0 |
| SG&A Expenses | $6,976 | $11,537 | $5,372 | $4,402 |
| Sales & Mktg Exp. | $0 | $6,785 | $0 | $0 |
| Other Operating Expenses | $49,202 | $0 | $0 | $0 |
| Operating Expenses | $60,812 | $26,936 | $23,227 | $19,757 |
| Operating Income | -$62,480 | -$27,942 | -$23,913 | -$20,645 |
| % Margin | -23,226.8% | -9,314% | -12,652.4% | -7,646.3% |
| Other Income/Exp. Net | $8,717 | -$10,204 | $240 | $707 |
| Pre-Tax Income | -$53,763 | -$38,146 | -$23,673 | -$19,938 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$53,763 | -$38,146 | -$23,673 | -$19,938 |
| % Margin | -19,986.2% | -12,715.3% | -12,525.4% | -7,384.4% |
| EPS | -3.54 | -4.86 | 0.056 | -0.34 |
| % Growth | 27.2% | -8,841% | 116.4% | – |
| EPS Diluted | -3.54 | -4.86 | 0.056 | -0.34 |
| Weighted Avg Shares Out | 15,198 | 7,856 | 19,187 | 19,187 |
| Weighted Avg Shares Out Dil | 15,198 | 7,856 | 19,187 | 19,187 |
| Supplemental Information | – | – | – | – |
| Interest Income | $423 | $3 | $39 | $3 |
| Interest Expense | -$1,102 | $1,659 | $137 | $0 |
| Depreciation & Amortization | -$7,612 | $532 | $495 | $336 |
| EBITDA | -$62,480 | -$27,410 | -$23,041 | -$19,602 |
| % Margin | -23,226.8% | -9,136.7% | -12,191% | -7,260% |